Apotheek J. Moonen: what changed
What changed
Apotheek J. Moonen
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
€191,526
2024 · €210,525-€18,999
Equity
€590,242
2024 · €861,008-€270,766
Cash
€218,678
2024 · €260,346-€41,668
Balance sheet total
€1.5m
2024 · €1.8m-€249,470
Largest movements
Assets
- Receivables after one year -€130,000
no longer reported in 2025 (was €130,000)
- Receivables within one year -€73,674
down €73,674 (-25.0%), from €294,465 to €220,791
of which Trade receivables: -€58,537
- Stocks and contracts +€44,014
up €44,014 (+18.9%), from €232,781 to €276,794
- Cash -€41,668
down €41,668 (-16.0%), from €260,346 to €218,678
mainly Contributions, distributions and other (-€462,292) and Investment in fixed assets (net) (-€56,652)
- Deferred charges and accrued income -€19,521
down €19,521 (-37.6%), from €51,920 to €32,399
Equity and liabilities
- Reserves -€270,766
down €270,766 (-31.9%), from €848,608 to €577,842
- Other debts +€133,582
up €133,582 (+104%), from €128,439 to €262,022
- Debts after one year -€56,253
down €56,253 (-10.5%), from €535,740 to €479,487
- Trade debts -€41,153
down €41,153 (-22.6%), from €182,275 to €141,121
Income statement
- Gross operating margin -€27,488
down €27,488 (-5.5%), from €504,312 to €476,825
- Staff costs -€15,142
down €15,142 (-16.2%), from €93,207 to €78,066
- Financial income -€6,240
down €6,240 (-47.2%), from €13,223 to €6,984
- Taxes -€5,592
down €5,592 (-5.7%), from €97,845 to €92,253
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€210,525
Gross operating margin
-€27,488
Staff costs
+€15,142
Depreciation
-€1,499
Other operating charges
-€1,024
Other operating items
+€731
Financial income
-€6,240
Financial charges
-€4,213
Taxes
+€5,592
Result 2025
€191,526
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€524,163
Investment
-€46,652
Financing
-€519,180
Cash 2024
€260,346
From operations (derived)
+€524,163
Net result for the year
+€191,526
Depreciation
+€75,273
Receivables after one year
+€130,000
Stocks and contracts
-€44,014
Receivables within one year
+€73,674
Deferred charges and accrued income
+€19,521
Trade debts
-€41,153
Tax, wage and social debts
-€14,459
Other debts
+€133,582
Accrued charges and deferred income
+€214
Investment (derived)
-€46,652
Investment in fixed assets (net)
-€56,652
Current investments
+€10,000
Financing
-€519,180
Debts after one year
-€56,253
Current portion of long-term debt
-€635
Contributions, distributions and other
-€462,292
Cash 2025
€218,678
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,796,327 | €1,546,857 | -€249,470 | -13.9% |
| Fixed assets | 21/28 | €696,816 | €678,194 | -€18,621 | -2.7% |
| Tangible fixed assets | 22/27 | €696,816 | €678,194 | -€18,621 | -2.7% |
| Land and buildings | 22 | €568,181 | €539,293 | -€28,888 | -5.1% |
| Plant, machinery and equipment | 23 | €29,561 | €30,835 | +€1,274 | +4.3% |
| Furniture and vehicles | 24 | €98,910 | €64,393 | -€34,517 | -34.9% |
| Other tangible fixed assets | 26 | €164 | €3,673 | +€3,510 | +2,145% |
| Assets under construction and advance payments | 27 | - | €40,000 | +€40,000 | |
| Current assets | 29/58 | €1,099,511 | €868,663 | -€230,849 | -21.0% |
| Amounts receivable after more than one year | 29 | €130,000 | - | -€130,000 | |
| Other amounts receivable | 291 | €130,000 | - | -€130,000 | |
| Stocks and contracts in progress | 3 | €232,781 | €276,794 | +€44,014 | +18.9% |
| Stocks | 30/36 | €232,781 | €276,794 | +€44,014 | +18.9% |
| Amounts receivable within one year | 40/41 | €294,465 | €220,791 | -€73,674 | -25.0% |
| Trade receivables | 40 | €277,678 | €219,141 | -€58,537 | -21.1% |
| Other amounts receivable | 41 | €16,787 | €1,650 | -€15,136 | -90.2% |
| Current investments | 50/53 | €130,000 | €120,000 | -€10,000 | -7.7% |
| Cash at bank and in hand | 54/58 | €260,346 | €218,678 | -€41,668 | -16.0% |
| Deferred charges and accrued income | 490/1 | €51,920 | €32,399 | -€19,521 | -37.6% |
| Total equity and liabilities | 10/49 | €1,796,327 | €1,546,857 | -€249,470 | -13.9% |
| Equity | 10/15 | €861,008 | €590,242 | -€270,766 | -31.4% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €848,608 | €577,842 | -€270,766 | -31.9% |
| Distributable reserves | 133 | €848,608 | €577,842 | -€270,766 | -31.9% |
| Amounts payable | 17/49 | €935,319 | €956,615 | +€21,296 | +2.3% |
| Amounts payable after more than one year | 17 | €535,740 | €479,487 | -€56,253 | -10.5% |
| Financial debts | 170/4 | €535,740 | €479,487 | -€56,253 | -10.5% |
| Amounts payable within one year | 42/48 | €395,688 | €473,023 | +€77,335 | +19.5% |
| Current portion of amounts payable after more than one year | 42 | €56,844 | €56,209 | -€635 | -1.1% |
| Trade debts | 44 | €182,275 | €141,121 | -€41,153 | -22.6% |
| Suppliers | 440/4 | €182,275 | €141,121 | -€41,153 | -22.6% |
| Taxes, remuneration and social security | 45 | €28,130 | €13,671 | -€14,459 | -51.4% |
| Taxes | 450/3 | €17,178 | €3,984 | -€13,194 | -76.8% |
| Remuneration and social security | 454/9 | €10,953 | €9,687 | -€1,265 | -11.6% |
| Other amounts payable | 47/48 | €128,439 | €262,022 | +€133,582 | +104% |
| Accrued charges and deferred income | 492/3 | €3,891 | €4,104 | +€214 | +5.5% |
| Non-recurring operating income | 76A | €28,037 | - | -€28,037 | |
| Remuneration, social security and pensions | 62 | €93,207 | €78,066 | -€15,142 | -16.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €73,774 | €75,273 | +€1,499 | +2.0% |
| Other operating charges | 640/8 | €1,504 | €2,528 | +€1,024 | +68.1% |
| Non-recurring operating charges | 66A | €731 | - | -€731 | |
| Gross operating margin | 9900 | €504,312 | €476,825 | -€27,488 | -5.5% |
| Operating profit (loss) | 9901 | €335,096 | €320,958 | -€14,138 | -4.2% |
| Financial income | 75/76B | €13,223 | €6,984 | -€6,240 | -47.2% |
| Recurring financial income | 75 | €13,223 | €6,984 | -€6,240 | -47.2% |
| Financial charges | 65/66B | €39,950 | €44,163 | +€4,213 | +10.5% |
| Recurring financial charges | 65 | €39,950 | €44,163 | +€4,213 | +10.5% |
| Profit (loss) for the period before taxes | 9903 | €308,370 | €283,779 | -€24,591 | -8.0% |
| Income taxes | 67/77 | €97,845 | €92,253 | -€5,592 | -5.7% |
| Profit (loss) for the period | 9904 | €210,525 | €191,526 | -€18,999 | -9.0% |
| Profit (loss) for the period to be appropriated | 9905 | €210,525 | €191,526 | -€18,999 | -9.0% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.